These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37737653)

  • 1. FXII contact activation products have an inhibitory effect on αFXIIa.
    Xu LC; Siedlecki CA
    J Biomed Mater Res A; 2024 Aug; 112(8):1213-1223. PubMed ID: 37737653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.
    Golas A; Pitakjakpipop H; Rahn MS; Siedlecki CA; Vogler EA
    Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of contact activation pathways of coagulation factor XII in plasma.
    Chatterjee K; Guo Z; Vogler EA; Siedlecki CA
    J Biomed Mater Res A; 2009 Jul; 90(1):27-34. PubMed ID: 18481791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.
    Ivanov I; Matafonov A; Sun MF; Cheng Q; Dickeson SK; Verhamme IM; Emsley J; Gailani D
    Blood; 2017 Mar; 129(11):1527-1537. PubMed ID: 28069606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive-protein adsorption in contact activation of blood factor XII.
    Zhuo R; Siedlecki CA; Vogler EA
    Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderation of prekallkrein-factor XII interactions in surface activation of coagulation by protein-adsorption competition.
    Chatterjee K; Thornton JL; Bauer JW; Vogler EA; Siedlecki CA
    Biomaterials; 2009 Oct; 30(28):4915-20. PubMed ID: 19552950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amidolytic, procoagulant, and activation-suppressing proteins produced by contact activation of blood factor XII in buffer solution.
    Golas A; Yeh CH; Siedlecki CA; Vogler EA
    Biomaterials; 2011 Dec; 32(36):9747-57. PubMed ID: 21955686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
    Mitropoulos KA
    Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.
    Woodruff RS; Xu Y; Layzer J; Wu W; Ogletree ML; Sullenger BA
    J Thromb Haemost; 2013 Jul; 11(7):1364-73. PubMed ID: 23692437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.
    Mutch NJ; Waters EK; Morrissey JH
    J Thromb Haemost; 2012 Oct; 10(10):2108-15. PubMed ID: 22905925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.
    Puy C; Tucker EI; Wong ZC; Gailani D; Smith SA; Choi SH; Morrissey JH; Gruber A; McCarty OJ
    J Thromb Haemost; 2013 Jul; 11(7):1341-52. PubMed ID: 23659638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface dependent contact activation of factor XII and blood plasma coagulation induced by mixed thiol surfaces.
    Bauer JW; Xu LC; Vogler EA; Siedlecki CA
    Biointerphases; 2017 May; 12(2):02D410. PubMed ID: 28514863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoactivation of blood factor XII at hydrophilic and hydrophobic surfaces.
    Zhuo R; Siedlecki CA; Vogler EA
    Biomaterials; 2006 Aug; 27(24):4325-32. PubMed ID: 16644008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-chain factor XII: a new form of activated factor XII.
    Ivanov I; Matafonov A; Gailani D
    Curr Opin Hematol; 2017 Sep; 24(5):411-418. PubMed ID: 28604413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contact activation of blood plasma and factor XII by ion-exchange resins.
    Josh Yeh CH; Dimachkie ZO; Golas A; Cheng A; Parhi P; Vogler EA
    Biomaterials; 2012 Jan; 33(1):9-19. PubMed ID: 21982294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
    Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic properties of activated FXII.
    Braat EA; Dooijewaard G; Rijken DC
    Eur J Biochem; 1999 Aug; 263(3):904-11. PubMed ID: 10469157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the histidine-rich glycoprotein domains responsible for contact pathway inhibition.
    Truong TK; Malik RA; Yao X; Fredenburgh JC; Stafford AR; Madarati HM; Kretz CA; Weitz JI
    J Thromb Haemost; 2022 Apr; 20(4):821-832. PubMed ID: 34967109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mathematical modeling of material-induced blood plasma coagulation.
    Guo Z; Bussard KM; Chatterjee K; Miller R; Vogler EA; Siedlecki CA
    Biomaterials; 2006 Feb; 27(5):796-806. PubMed ID: 16099033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A site on factor XII required for productive interactions with polyphosphate.
    Shamanaev A; Litvak M; Cheng Q; Ponczek M; Dickeson SK; Smith SA; Morrissey JH; Gailani D
    J Thromb Haemost; 2023 Jun; 21(6):1567-1579. PubMed ID: 36863563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.